Home     e-Mail     Directory     Contact us    
 

PROFESSOR   HAKAM   FAEQ   AL-HADIDI 

Advisor to the President

 

NAME :                         Hakam Faeq Al-Hadidi

DATE OF BIRTH:          9 August 1950

PLACE OF BIRTH:        Salt, Balqa, Jordan

NATIONALITY:             Jordanian

MARITAL STATUS:      Married with three children

SEX:                             Male

LANGUAGES:               Arabic and English

ADDRESS:                  

                                                The Hashemite University

The Presidency

P.O.Box 330127

Zarqa, 13115, Jordan

                                    Tel: 05 3903333, ext: 4488                     

                                                                       

                                  

                                     Al-Rabia, P.O. Box : 1311 Amman, Jordan.

                                     Tel: 00962 6 5533433

 Mobile: 00962 79 64 555 66

Ph.D. Pharmacology (Clinical Pharmacology), St. Mary’s Hospital Medical School , University of London , London, UK , 1987.

Professional and Linguistic Assessment Board (PLAB) London, UK , 1979.

  Medical Doctor, 1975

1975-1978

Internship, General Practitioner and Resident in Internal Medicine. Al-Hussein (Salt) and Al-Basheer (Amman) Hospitals. Ministry of Health, Jordan .

 

1979-1983

Senior House Officer in General Medicine in various London Hospitals, UK . and Jordan University Hospital , Amman, Jordan .  

 

1984-1987

Post-graduate studies, Pharmacology and Oncology Departments, St. Mary’s Hospital Medical School , University of London , London, UK .

 

1988-1995

Assistant Professor / Department of Pharmacology, Faculty of Medicine, JUST, Jordan .

 

1995-May 2000

Associate Professor /Department of Pharmacology,  Faculty of Medicine, JUST, Jordan .

 

Sep1996-Jun 1997

Visiting Scientist, Department of Cancer Research and Molecular Biology, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway .

 

Jul 1997-Jan 1998

Associate Professor, Department of Medical Genetics, University Hospital ,

Trondheim, Norway .

 

May 22. 2000 - to date

Professor of Pharmacology, JUST, Jordan .

1992-1994

Chairman, Department of Pharmacology, Faculty of Medicine, JUST, Jordan

 

Jan1994-Sep1994

Assistant Dean, Faculty of Medicine, JUST, Jordan .

 

Sep1994-Sep1996

Vice-Dean, Faculty of Medicine, JUST, Jordan .

 

1.9.1998-1.9.2001

Vice Dean, Faculty of Medicine, JUST, Jordan .

 

1.9.2001-30.8.2002

Dean, Faculty of Scientific Research, JUST, Jordan .

 

1.9.2002-17.12.2002

Vice President, and Acting President of The Hashemite University (public), Zarqa, Jordan .

 

18.12.2002-1.12.2004

President, The Hashemite University (public), Zarqa, Jordan .

 

1.11.2010- to date

Advisor to The President, The Hashemite University , Zarqa, Jordan .

I have participated in teaching the following courses for students at faculties of Medicine, Pharmacy, Dentistry and Nursing:

1.        Pharmacology for Medical students (MED 355), JUST.

2.        Pharmacology for Pharmacy students (MED 350) JUST.

3.        Pharmacology for Pharmacy students (MED 451), JUST

4.  Pharmacology for Dental students (MED 351), JUST

5.       Pharmacology for Nursing students (MED 255), JUST

6.  Toxicology for Nursing students (MED 251), JUST.

7.  Clinical Pharmacy for Pharmacy students (Pharm 441 and 442),

8.  Dental Therapeutics and Practice (DENT 321) for Dental students, JUST.

9.       Pharmacology for Nursing and Midwifery students, Nusabya Al- Mazeniah college of Nursing and Midwifery, Ministry of Health, Jordan.

10.Pharmacology and Therapeutics (MED 751) for postgraduate Nursing Students, JUST.

      During these courses, and in addition to the main subjects in     pharmacology, the concepts of essential drug list as well as the rationale      use of drugs, the pharmacokinetics, pharmacodynamics including plasma drug monitoring, drug-drug interaction, bioavailability, bioequivalence and the Pharmacogenetics has been given with  great care.

11.   I have participated in continuous medical education and training of  Pharmacists working at The Ministry of Health and the Royal Medical Services on the Rational Use of Drugs (RUD), and the concept of drug development and clinical trials as well as the Guidelines of Good Clinical Practice.

12. I have participated in teaching pharmacology in the integrated modular  

      system for Dental as well as Pharm.D students.

13.   Now, I am participating in teaching pharmacology and clinical    

      pharmacology in the integrated modular system of medical education for  

              second and third year  Medical Students.

14.   I am participating in teaching General Pharmacology course for second 

      year Medical students.

15.   I am participating in teaching advanced pharmacology for postgraduate 

     Master degree students in Basic Medical Sciences.

1. A Workshop on Medical Education, Jordan University of Science and  Technology (JUST), Jordan .

2. Training Workshop in Mass-Spectrometry, Faculty of Medicine, Norwegian University of Science and Technology, 1997, Trondheim, Norway .

3.  API-300 Basic User Training Course, held by Perkin Elmer, Green, 1997,    England

4. A Workshop on the Action Plan for National Drug Policy, 1998, Amman,  Jordan ,

5. A Workshop on Organization of Higher Education Institutions in Jordan ,

     1998, Jordan University ,.

6. A Workshop on Higher Education (Scientific Research and Development), 1998, The Hashemite University , Jordan ,.

7. A Workshop on Community-Based learning in Medical Schools, 1999, Wad Madani, Sudan,

8. A training Course and Faculty Development Workshop on Tutoring Skills, College of Medicine and Medical Sciences, Arabian Gulf University, Bahrain, 1999.

9.The 6th International Training Course in Teaching Rational Pharmacotherapy, 19-28 July 1999, Groningen ,  The Netherlands .

10.     A workshops and Training courses for Pharmacists on rational use of Drugs, Ministry of Health, Amman ,

11.     Training course on Pharmacovigilance, 7-18 May 2001, Uppsala, Sweden .

12.     Workshop on Rational Use of Drugs, Royal Medical  Services , 20 August 2001, Amman, Jordan ,

 13.Workshop on Pharmacovigilance, 2001, JUST, Jordan .

 14.Training course Drug and Therapeutic Committee, 2001, Kenya .   

        15. Workshop on herbal medicine and medicinal plants, 2002, Amman, Jordan .        

                       16.  Workshop on organization of Higher Education in Jordan, 2002,  Jordan .

    17.  Workshop on Electronic Learning as a tool in education, 2004, The Hashemite  University, Zarqa, Jordan .

   18. Video on demand and its application for university education. 2004, The Hashemite University , Zarqa, Jordan

    19. Workshop on bioavailability and bioequivalence, 2007,  Amman, Jordan .

    20. Workshop on Clinical trials, future prospective, 2007, Amman, Jordan .

    21. Workshop on Institutional Review Board and clinical trial, 2008, Amman, Jordan .

    22. Workshop on drug development and Clinical Research, 2008, Amman, Jordan .

    23. First meeting for the Eastern Mediterranean and Arab Forum on Bioethics in Research, 12-14 August 2008, Cairo, Egypt .

    24. Clinical trials Conference in the Middle East and North Africa (MENA) region, Oct. 2008, Amman, Jordan .

    25. Workshop on Health Research Ethics and IRB, review experiences for public and private health sectors in corporation with WHO, May 2009, Amman, Jordan.

   26. Workshop on Scientific Research priorities and Needs in Jordan , The Higher Council of Science and Technology, Sep. 2009, Amman, Jordan .

       27. The Fourth Scientific Research Conference in Jordan , November, 2009,   Amman, Jordan .

       28. Workshop on National Scientific and Technological strategies for the coming 2011-2015 years in Jordan, The Higher Council of Science and Technology, Jan. 2010, Amman, Jordan.

       29. Clinical Investigation Training Program, JFDA, May 2010, Amman, Jordan .

1.        Member of the Jordanian Medical Association, 1975- to date.

2.        Editorial Board Member, Pharmacogenetics, 1991-March 1999.

3.  Chairman of University (JUST) Scientific and Research Committee, JUST, Jordan, 1999- 30.8.2002.

4.  Member of Curriculum Committee, Faculty of medicine, JUST.2001.

5.  Member of University Dean’s Council. JUST, 2001-2002.

6.  Member of University Appointment and Promotion Committee, JUST, 2001-2002.

7.  Member of University Council, JUST, 2001-2002.

8.  Member of the Higher Education Council, Ministry of Higher Education,  

     Jordan , Oct 2002-1/12/2004.

9.  Member of the Higher Education Committee, Ministry of Higher education,

     Jordan , 2002-Dec 2004.

        10. Member of the Committee for Selection Private Universities, Ministry of

              Higher Education, Jordan , 2004.

11.Chairman of University Dean’s Council. The Hashemite University, Jordan , 2002-Dec 2004

12.Chairman of University Appointment and Promotion Committee,

       The Hashemite University, Jordan , 2002-Dec 2004

13.Chairman of University Council, The Hashemite University, Jordan , 2002-Dec 2004.

14.Member of The Board of Trustees, The Hashemite University, Jordan , 2002-Dec 2004.

        15.Member of Jordan Drug Policy Committee, Ministry  of  Health, Jordan  

             1997-1999.

16.Member of the National Committee on the Rational Use of Drugs, Ministry of Health, Jordan , 1998.

17. Member of the Committee for Drug Treatment Guidelines (DTG),   

       Ministry of Health, Jordan , 1999.

        18 . Member of Pharmacy Rules Committee, Ministry of  Health, Jordan,

               1999.

        19.   Member of the Jordanian Committee for establishing Rules and

                Regulations for drugs and consumable tenders, Ministry of Health,  

                Jordan , 2000.

20.  Member of the Committee for Good Clinical Practice, Ministry  of

        Health, Jordan ,  2001.

21.  Member of Drug and Therapeutic Committee, JUST, Jordan.

22. Member of Committee for drug studies on humans, Ministry of Health, Jordan, 2000.

23. Member of Higher Committee for drugs and pharmacy, Ministry of Health, Jordan , 2001.

24.  Member of National Pharmacovigilance Committee, Ministry of Health,

       Jordan , 2000.

25.  Member of the Committee for establishment of allergenic extracts and

       drugs guidelines, Ministry of Health, Jordan . 2001.

26.  Member of bioavailability and bioequivalence Committee, Ministry of

        Health, Jordan , 2003.

27.  Member of The Higher Committee for Drugs and  Pharmacy, Ministry of

        Health, Jordan , 2003.

28. Member of the Higher Clinical Research Committee, Food and Drug

       Administration, Jordan 2006 -2008

29..Chairman of Institutional Review Board (IRB)-Independent Ethics  

        Committee), JUST, 2005 – 2009.

30.     Member of Board of Directors, Al-Kindy Pharmaceutical Industry,  

       2008- to date.

31.    Member of The Board of Trustees, Jadara University (Private), 

       2005-2008. 

32.   Chairman of Medical and Pharmaceutical Section Research Committee, The Higher Council of Science and Technology, Jordan, 2009 to date.

33.   Member of Board of Directors, Jordan Food and Drug Administration, 2008-to date.

34.    Member of  The Higher Education Council ( Royal Decree), Ministry of Higher Education of Jordan , 29 June 2010- to date. 

1. H. Hadidi, C. Coulter and J. Idle Cyclophosphamide “metabolic index”- a means of estimating metabolic   activation of cyclophosphamide from urine. Acta Pharmacol Toxicol 1986; suppl v: 535

2. J. Idle and H. Hadidi Drug interactions with cyclophosphamide metabolism and disposition in mice. Acta Pharmacol Toxicol, 1986; suppl v: 1547.

3. B. Cartmel, M. Stockton, M. Crothers, H. Hadidi, J. Idle, J.Riodon and M. McNicol. Distribution of oxidation phenotypes in lung cancer families. Acta Pharmacol Toxicol, 1986; suppl v: 670.

4.Al-Hakam Hadidi and Jeffrey Idle.Combined thin-layer chromatography-photography-densitometry the quatitation of cyclophosphamide and its four principal urinary metabolites. J. Chromatography 1988; 427: 121 – 130.

5. H. F. Hadidi, Carmel E.A. Coulter, and Jeffrey Idle. Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients.Cancer research 1988; 48: 5167 – 5171.

6. Y. M. Irshaid, H.F. Hadidi, M. A. Abuirjeie and N.M.Rawashdeh.N-acetylation phenotyping using dapsone in a Jordanian population . Br. J. Clin. Pharmacol.,1991; 32: 289- 293.

7. M. A. Abuirjeie, Y.M. Irshaid, H.F. Hadidi, and N.M. Rawashdeh. Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine .J. Clin. Pharm Ther. 1991; 16-255-247.

8. Y.M. Irshaid, H.F. Al-Hadidi and N.M. Rawashdeh. Lack of association between glucose-6.phosphate dehydrogenase deficiency and dextromethorphane O-demethylation polymorphism. Eur. J. Clin. Pharmacol. 1993; 44: 303-304.

9. Jeffrey Idle, M. Armstrong, Alan Boddy, Carol Boustead, Suzanne Cholerton, Jane Cooper, Ann Daly, Janice Ellis, Wendy Gregory Hakam Hadidi, Constance Hofer, John Holt and others. The pharmacogenetics of chemical carcinogenesis.Pharmacogenetics 1992; 2: 246-258.

10.Y.M. Irshaid, H.F. Al-Hadidi and N.M. Rawashdeh. Lack of association between glucose-6-phosphate dehydrogenase deficiency and dextromethorphane O-demethylation polymorphism. Eur. J. Clin. Pharmacol. 1993; 44: 303-304.

11.Y.M. Ir shaid, H.F. Al-Hadidi, M.A. Abuirjeie, N.M. Rawashdeh and    N.S. Garaibeh.     Acetylation of dapsone by human whole blood.  Inter.Clin. Pharmacol. Ther. Toxicol., 1993; 31: 18-22.

12.Y.M. Irshaid, H.F.Al-Hadidi and N.M. Rawashdeh.Dextromethorphan O-demethylation polymorphism in Jordanians. Eur. J. Clin. Pharmacol., 1993; 45: 271-273. N.M. Rawashdeh, H.F. Al-Hadidi, Y.M. Irshaid and A. Battah. Gastrointestinal dialysis of digoxin by cholestyramine. Pharmacol. Toxicol.,1993; 72: 245-248.

13. N.M. Rawashdeh, H.F. Al-Hadidi, Y.M. Irshaid and A. Battah.Gastrointestinal dialysis of digoxin by cholestyramine. Pharmacil. Toxicol., 1993; 72: 245-248.

 14.H.F.Al-Hadidi, Y.M.Irshaid and N.M. Rawashdeh.Metoprolol a-hydroxylation is a poor probe for debrisoquine oxidation (CYP2D6) plymorphism in Jordanians. Eur. J. Clin. Pharamcol., 1994; 47: 311-314.

15. H.F. Hadidi, S. Cholerton, S.C. Monkman, M. Armstrong, Y.M.Irshaid, N.M. Rawashdeh, A.K. Daly and J.R. Idle.Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians. Pharmacogenetics 1994; 4: 159-161.

16.H.F.Hadidi, S. Cholerton, S. Atkinson, Y.M. Irshaid, N.M. Rawashdeh and J.R. Idle.The N-oxidation of trimethylamine in a Jordanian population.Br. J. Clin. Pharmacol., 1995; 39: 179-181.

17. H.F.Hadidi, Y.M. Irshaid, R.L. Woosley, J.R. Idle and D.A. Flockhart. S-mephenytoin hydroxylation phenotypes in a Jordanian population. Clin. Pharmacol. Ther., 1995; 58: 542-547.

18. M. al-Salem, H. Hadidi and R. Alwash.The effects of diclofenac on cryo-induced miosis. Int. Ophtholmol., 1996; 20: 193-195.

19.Y.M. Irshaid, H.F. Al-Hadidi, A. Latif, F. Awwadi, M. al-Zoubi and N.M.Rawashdeh.Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation. Eur. J. Drug Metab. Pharmacokinet., 1996; 21: 301-304.

20. H. Hadidi, K. Zalsen, J. R. Idle and S. Cholerton.A single amino acid substitution (Leu 160 His) in cytochrome P450 CYP2A6 causes swithching from 7-hydroxylation to 3-hydroxylation of coumarin.Food Chem. Toxicol., 1997; 35: 903-907.

21. H. Hadidi, Y. Irshaid, C. Broberg, A. Brunsvik, S. Cholerton, K.Zahlsen and J.R. Idle. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6. Eur. J. Clin. Pharmacol. 1998; 54:437-441.

22. H. Hadidi, G. Guzey and J.R. Idle.Pharmacogenetics and toxicological consequences of human drug oxidation and reduction.General and Applied Toxicology Textbook 1999, Published by MacMillan Reference Ltd. Edited by B. Ballantyne, T. Marrs and T. Syversen. Volume 1, Second Edition, Chapter 10, p 215-250.

23. L. Grevle1; C. Guzey1, MD; H. Hadidi, MD, PhD; R. Brennersted1; JR. Idle1, PhD; J. Aasly2, MD, PhD.Allelic association between the DRD2 TaqI A polymorphism and Parkinson’s disease.Movement Disorders , 2000, 15,(6), 1070-1074.

24. Sameer Otoom and Hakam Hadidi Seizure Induced by Antiepileptic Drugs.Annals of Saudi Medicine, 20, (4), 2000.

25. Haytham Eloqayli, Hong Qu, Geirmond Unsgard, Olav Sletvold, Hakam Hadidi and Ursula Sonnewald. Effects of Pentylentetrazole and glutamate on metabolism of [U-13C] glucose in cultured cerebellar granule neurons.Neurochemistry International 2002 Feb; 40(2): 181.

26. S.Otoom, A.Batieha, H.Hadidi, M. Hasan, and K.Al-Saudi.

       Evaluation of Drug Use in Jordan Using WHO Prescribing Indicators.

       East Mediterranean Health Journal, Vol8, No 4/5, 2002.

27. S.Otoom, A.Batieha, H.Hadidi, M. Hasan, and K.Al-Saudi.

       Evaluation of Drug Use in Jordan Using WHO Patient Care and Health Facility Indicators.  East Mediterranean Health Journal, Vol8, No 4/5, 2002.

28. S.Otoom, M.Nusier, M.Hasan, H.Hadidi, R.Samawi,A.M.Younes,M.Darweesh. and N.R.Boulatova Association of Polycystic Ovaries with the Use of  Valproic   Acid in Jordannian Epileptic Patients. Clinical Drug Investigation. 23 (8), 2003.

29. Haytham AlOqayli, Carl B. Dahl, K Gunnar Gotestam, Germund Unsgard, Hakam Hadidi, Ursula Sonnewald.

       Pentylenetetrazole decreases metabolic glutamate turnover in rat brain.

       J. Neurochem. 2003, Jun; 85(5): 1200-7.

30. H.F. Hadidi.  The effect of famotidine and diclofenac on  

      theophylline pharmacokinetics in the rabbit. In preparation for   

      Saudi Pharmaceutical Journal.

1. Professor Saad Hijazi M.D., Ph.D

    Professor of Public Health and Nutrition

    Former President of Jordan University of science and technology

    Faculty of Medicine

    Jordan University of Science and Technology

    P.O.Box 3030, Irbid 22110, Jordan

    Tel: 00962 2 7201070

    Mobile : 00962 79 560 40 80

                   e-mail: hijazi@just.edu.jo

 

       2. Professor Mazen M. Hasan M.D. Ph.D.

             Chairman

             Department of Pharmacology

    Faculty of Medicine

    Jordan University of Science and Technology

    P. O. Box  3030, Irbid 22110, Jordan

   Tel: 00962 2 720 1000 ext: 23865

    e-mail: mazen@just.edu.jo

 

2.  Professor Kassim H. Saudi  M.D., Ph.D

              Professor of Pharmacology

              Department of Pharmacology                 

     Faculty of Medicine <

     Jordan University of Science and Technology

     P.O. Box 3030

     Irbid 22110, Jordan

     Tel: 00962  2 725 1440,  Mobile: 00962 79 55 45 231

     E-mail: kahakas@just.edu.jo, or  kassim44@yahoo.co.jo

Back
[Home]     [Site Map]     [News Center]    [Contact us]    [Send Feed back]
The Hashemite University, Tel: +962 (5) 3903333 Fax: +962 (5) 3826613 Email: huniv@hu.edu.jo Copyright © 2011, All Rights Reserved.